InsiderSignal.AI

InsiderSignal.ai

TRU - Transunion

Insider Sale by Chaouki Steven M (Pres, US Markets)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Chaouki Steven M, serving as Pres, US Markets at Transunion (TRU), sold 5,000 shares at $70.00 per share, for a total transaction value of $350,000.00. Following this transaction, Chaouki Steven M now holds 89,711 shares of TRU.

This sale represents a 5.00% decrease in Chaouki Steven M's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, April 2, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 6, 2026, 4 days after the trade was made.

Transunion operates in the FINANCIAL SERVICES sector, specifically within the FINANCIAL DATA & STOCK EXCHANGES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Chaouki Steven M

Chaouki Steven M

Pres, US Markets

Steven M. Chaouki is an independent Class I director at MAIA Biotechnology, Inc. (MAIA), appointed to the board in 2021 and serving on the Audit Committee as a designated financial expert.[[1]](https://fintool.com/app/research/companies/MAIA/people/steven-chaouki)[[2]](https://ir.maiabiotech.com/news-events/press-releases/detail/6/maia-biotechnology-inc-announces-the-appointment-of)[[4]](https://maiabiotech.com/about/board-of-directors/) Age 52, he brings over two decades of experience in financial services and capital markets.[[2]](https://ir.maiabiotech.com/news-events/press-releases/detail/6/maia-biotechnology-inc-announces-the-appointment-of) Currently, Chaouki serves as President, U.S. Markets & Consumer Interactive at TransUnion, overseeing business lines providing information to financial services, insurance, and consumer credit protection services; he previously held the role of Executive Vice President, Financial Services at TransUnion from 2013 to 2019 and earlier positions at HSBC in card/retail services and auto finance.[[1]](https://fintool.com/app/research/companies/MAIA/people/steven-chaouki)[[4]](https://maiabiotech.com/about/board-of-directors/)[[5]](https://www.bu.edu/questrom/profiles/steven-chaouki/) He holds an MBA from the University of Chicago Booth School of Business and a B.S.B.A. from Boston University.[[1]](https://fintool.com/app/research/companies/MAIA/people/steven-chaouki)[[2]](https://ir.maiabiotech.com/news-events/press-releases/detail/6/maia-biotechnology-inc-announces-the-appointment-of) Chaouki has demonstrated commitment to MAIA through recent insider purchases, including 40,849 shares on December 22, 2025, for approximately $50,000, alongside stock options, increasing his beneficial ownership to around 262,602 shares.[[1]](https://fintool.com/app/research/companies/MAIA/people/steven-chaouki)[[3]](https://www.investing.com/news/insider-trading-news/chaouki-steven-m-buys-maia-biotechnology-shares-worth-49999-93CH-4421151)[[7]](https://www.gurufocus.com/insider/104984/steven-m-chaouki)

View full insider profile →

Trade Price

$70.00

Quantity

5,000

Total Value

$350,000.00

Shares Owned

89,711

Trade Date

Thursday, April 2, 2026

7 days ago

SEC Filing Date

Monday, April 6, 2026

Filed 4 days after trade

FINANCIAL SERVICESFINANCIAL DATA & STOCK EXCHANGES

About Transunion

Company Overview

No company information available
View news mentioning TRU

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5421155

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime